Comprehensive safety assessment using non-human primate models

Published on 22 November 2024 at 11:42

To investigate the possible toxicity of novel drug candidates before they are introduced to the human body, safety evaluation is a crucial component of preclinical research. Our toxicity research division at Creative Biolabs is staffed by interdisciplinary experts and conveniently located preclinical facilities worldwide, guaranteeing that the possible toxicity of your medication is accurately described. You can always rely on our team's extensive preclinical drug development knowledge to provide you with trustworthy safety assessment findings.

For more information:Comprehensive safety assessment using non-human primate models

Add comment

Comments

There are no comments yet.

Create Your Own Website With Webador